Female infertility. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: Group A will receive clomiphene citrate (100 mg, Iran Hormone) on cycle day 3-7 ( for 5 days). Intervention 2: Intervention group: Group B will receive Letrozole (5
Sponsors
Mehr medical institute
Rasht University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
No minimum to 38 Years
Inclusion criteria
Inclusion criteria: Age = 38 years• Basal FSH level <10 Patients without history of allergic reactions to clomiphene Mild male factor infertility Unexplained infertility Anovolatory patients who have not been pregnant despite the use of ovulation induction techniques and appropriate follicles
Exclusion criteria
Exclusion criteria: No response to ovulation induction Patients with large number of follicles who cannot receive hCG
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: Seven weeks after intrauterine insemination. Method of measurement: Observation of gestational sac on transvaginal ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of follicles = 18 mm. Timepoint: On hCG administration day. Method of measurement: By transvaginal ultrasound.;Follicular size on hCG day. Timepoint: On hCG administration day. Method of measurement: By transvaginal ultrasound.;Duration of ovarian stimulation. Timepoint: At the end of ovarian stimulation. Method of measurement: Number of days.;Endometrial thickness on hCG administration day. Timepoint: On hCG administration day. Method of measurement: By transvaginal ultrasound.;Gonadotropin dosage. Timepoint: At the end of ovarian stimulation. Method of measurement: International Units. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Mehrafza
Mehr medical institute
Outcome results
None listed